Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial.

@article{Parkes2008EffectOS,
  title={Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial.},
  author={Gary Parkes and Trisha Greenhalgh and Mark D Griffin and Richard Dent},
  journal={BMJ},
  year={2008},
  volume={336 7644},
  pages={598-600}
}
OBJECTIVE To evaluate the impact of telling patients their estimated spirometric lung age as an incentive to quit smoking. DESIGN Randomised controlled trial. SETTING Five general practices in Hertfordshire, England. PARTICIPANTS 561 current smokers aged over 35. INTERVENTION All participants were offered spirometric assessment of lung function. Participants in intervention group received their results in terms of "lung age" (the age of the average healthy individual who would perform… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 7 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 147 extracted citations

Ist ein Screening auf COPD sinnvoll?

Der Pneumologe • 2017
View 6 Excerpts
Highly Influenced

Dawning of a new lung age?

Primary care respiratory journal : journal of the General Practice Airways Group • 2012
View 2 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 15 references

Antidepressants for smoking cessation.

The Cochrane database of systematic reviews • 2007

Biomedical riskassessmentas an aid for smoking cessation

BurnandB BizeR, MuellerY, J Cornuz
Cochrane Database Syst Rev • 2005

Physician advice for smoking cessation.

The Cochrane database of systematic reviews • 2004

Recent trends inphysiciandiagnosedCOPD inwomenandmen in the UK

JB Soriano, WC Maier, +3 authors J Sykes
Thorax • 2000

Similar Papers

Loading similar papers…